Total Health
S

GI Cancers Expert Discussion: Pem vs. Gem+Cis for CCA with FGFR2 Fusions, Nivo for Resected EC/GEJC, 1L Chemo vs. Chemo+Pembro for EC, Nivo/Chemo/Nivo+Ipi for HER2- Advanced GC, Chemo+/-Nivo for Advanced GC/GEJC

By Total Health FEATURING Shikha Jain, May Cho, Cathy Eng, Arturo Loaiza-Bonilla, Aparna Parikh
By Total Health FEATURING Shikha Jain, May Cho, Cathy Eng, Arturo Loaiza-Bonilla, Aparna Parikh
321 views
March 11, 2021
1 Comment
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
07:35
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…

Feat. R. Kim, R. Mehta
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
09:42
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
16:53
Scripps MD Anderson Cancer Center

GC/GEJC/EC Trials - Evolving Landscape and Treatment Guidance

Feat. J. Hecht
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan
04:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phas…

Feat. K. Shitara
06:53
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
03:31
ecancer

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…

Feat. B. Gyawali
08:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…

Feat. M. Terashima
20:44
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Upper GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez